Theileria annulata sporozoite surface antigen (SPAG-1) contains neutralizing determinants in the C terminus
- PMID: 7517029
- DOI: 10.1111/j.1365-3024.1994.tb00328.x
Theileria annulata sporozoite surface antigen (SPAG-1) contains neutralizing determinants in the C terminus
Abstract
SPAG-1 is a surface antigen on Theileria annulata sporozoites that is a candidate both for inclusion in a subunit vaccine and as a ligand for host cell recognition. We have pinpointed major neutralizing epitopes to the C terminus. To facilitate this we expressed SPAG-1 as a series of defined fragments in the pGEX system. These constructs were validated by sequencing and by their spectrum of reactivity with monoclonal antibody (MoAb) BA4. This MoAb recognizes the elastin motif VGVAPG, that is predicted to occur three times in the N terminal half of SPAG-1. The recombinant proteins were then tested by Western blotting with a neutralizing MoAb (1A7) and two neutralizing bovine sera (10T and 34A). The results demonstrate that 1A7 and the bovine sera react with determinants unique to the C terminus. We mapped the neutralizing determinant recognized by MoAb 1A7 to a 16 residue sequence (residues 807-822) using synthetic peptides. Interestingly the bovine sera do not recognize the 1A7 epitope. The potential role of the C terminus as a ligand for host cell recognition and the implications for sub-unit vaccine production are discussed.
Similar articles
-
Conservation of neutralizing determinants between the sporozoite surface antigens of Theileria annulata and Theileria parva.Exp Parasitol. 1996 Apr;82(3):229-41. doi: 10.1006/expr.1996.0030. Exp Parasitol. 1996. PMID: 8631374
-
Mimicry of elastin repetitive motifs by Theileria annulata sporozoite surface antigen.Mol Biochem Parasitol. 1992 Jul;53(1-2):105-12. doi: 10.1016/0166-6851(92)90012-9. Mol Biochem Parasitol. 1992. PMID: 1501630
-
Polymorphism of SPAG-1, a candidate antigen for inclusion in a sub-unit vaccine against Theileria annulata.Mol Biochem Parasitol. 1994 Sep;67(1):1-10. doi: 10.1016/0166-6851(94)90090-6. Mol Biochem Parasitol. 1994. PMID: 7838169
-
Theileria annulata sporozoite antigen fused to hepatitis B core antigen used in a vaccination trial.Vaccine. 1995 Sep;13(13):1152-60. doi: 10.1016/0264-410x(95)00026-w. Vaccine. 1995. PMID: 8578798 Clinical Trial.
-
Theileria annulata: epitope mapping neutralizing antibodies using phage display.Exp Parasitol. 2000 Jan;94(1):42-4. doi: 10.1006/expr.1999.4463. Exp Parasitol. 2000. PMID: 10631079 No abstract available.
Cited by
-
Immuno-informatics Analysis to Identify Novel Vaccine Candidates and Design of a Multi-Epitope Based Vaccine Candidate Against Theileria parasites.Front Immunol. 2018 Oct 15;9:2213. doi: 10.3389/fimmu.2018.02213. eCollection 2018. Front Immunol. 2018. PMID: 30374343 Free PMC article.
-
A novel candidate vaccine for cytauxzoonosis inferred from comparative apicomplexan genomics.PLoS One. 2013 Aug 20;8(8):e71233. doi: 10.1371/journal.pone.0071233. eCollection 2013. PLoS One. 2013. PMID: 23977000 Free PMC article.
-
In silico analysis of sporozoite surface antigen 1 of Theileria annulata (TaSPAG1) for multi-epitope vaccine design against theileriosis.In Silico Pharmacol. 2023 Jul 19;11(1):16. doi: 10.1007/s40203-023-00153-5. eCollection 2023. In Silico Pharmacol. 2023. PMID: 37484780 Free PMC article.
-
Genome sequence of Babesia bovis and comparative analysis of apicomplexan hemoprotozoa.PLoS Pathog. 2007 Oct 19;3(10):1401-13. doi: 10.1371/journal.ppat.0030148. PLoS Pathog. 2007. PMID: 17953480 Free PMC article.
-
Development of a multi-epitope chimeric vaccine in silico against Babesia bovis, Theileria annulata, and Anaplasma marginale using computational biology tools and reverse vaccinology approach.PLoS One. 2025 Jan 24;20(1):e0312262. doi: 10.1371/journal.pone.0312262. eCollection 2025. PLoS One. 2025. PMID: 39854345 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources